Does HRT cause breast cancer?

Last reviewed July 6, 2026 by Dr. Sapna Jadhav, General Physician. Sources from ACOG, NHS, Mayo Clinic, CDC, NICE, NIH, Cochrane, and peer-reviewed journals.

Bottom lineCombined estrogen-progestogen HRT carries a small breast cancer increase - about one extra case per 1,000 women per year, fading after stopping - while estrogen-only HRT showed no increase and even fewer breast cancer deaths in long-term trials; micronized progesterone appears lower-risk, and vaginal estrogen carries no established risk at all.

Combined HRT is associated with a small increase in breast cancer risk; estrogen-only HRT is not - and the size of the increase is far smaller than most women fear.

What the evidence shows

• Combined HRT (estrogen plus progestogen, for women with a uterus): the Women's Health Initiative trial found roughly one extra breast cancer case per 1,000 women per year of use, with risk rising after about 3-5 years and declining after stopping.
• Estrogen-only HRT (after hysterectomy): the same trial found no increase - and over 20 years of follow-up, a slight reduction in breast cancer deaths.
• The 2019 Lancet meta-analysis of worldwide evidence confirmed the combined-HRT association and that longer use carries more risk.

Putting the size in perspective

The extra risk from combined HRT is comparable to the breast cancer risk associated with drinking about two units of alcohol a day or with being significantly overweight. It is real and worth counting - but it is a small addition to baseline risk, not a doubling or tripling.

What changes the risk

• Progestogen type: observational evidence suggests body-identical micronized progesterone carries a lower risk than older synthetic progestogens.
• Duration: risk accumulates with years of use, which is why guidelines recommend an annual review rather than a fixed stop date.
• Vaginal estrogen (creams, rings, pessaries for dryness): minimal absorption, no established breast cancer risk, and usable even by many women advised against systemic HRT.

Who needs a different conversation

A personal history of breast cancer generally rules out systemic HRT, and a strong family history or BRCA mutation moves the decision to a specialist - it does not automatically mean no.

Keep up mammogram screening on schedule while on HRT, and report any new breast lump or change promptly regardless of screening dates.

This is general information, not medical advice. Read the full evidence review: the risks of HRT.

Weigh it against your symptoms: menopause symptom score